A recent study highlighted in Forbes reveals that GLP-1 receptor agonists, popular as weight loss drugs, are experiencing declining usage among diabetics. While these drugs effectively aid in weight management, their adoption for diabetes treatment has decreased. This trend raises concerns about the balance between their benefits for weight loss and their role in managing diabetes, prompting further discussion on their optimal use in both contexts.
GLP-1s Are Growing In Popularity For Weight Loss But Losing Steam Among People With Diabetes, Study Suggests (Forbes)
0